Drug Makers Explore Financing for Research Efforts
By Peter Loftus of Dow Jones Newswires
Pharmaceutical companies, under pressure to cut costs while still churning out new drugs, are exploring outside financing for their research efforts.
Several large drug makers are considering deals similar to the kind announced last year by Eli Lilly & Co. (LLY), in which the Indianapolis company will receive up to $325 million from outside investors to help fund clinical trials of two experimental Alzheimer's disease treatments.
Read the rest of the April 7, 2009 story from WSJ.com.
Click here for more information.